


Tenpoint Therapeutics Ltd. Submits New Drug Application to U.S. FDA for BRIMOCHOLTM PF for the Treatment of Presbyopia

Agomab Announces Positive Topline Phase 2a Interim Results for AGMB-129 in Fibrostenosing Crohn’s Disease

Saniona’s Joint Venture, Cephagenix, Secures Seed Funding from AdBio Partners and AbbVie Ventures
